Sanofi
Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same

Last updated:

Abstract:

The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.

Status:
Grant
Type:

Utility

Filling date:

5 Nov 2021

Issue date:

27 Sep 2022